Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13297-35-3

Post Buying Request

13297-35-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13297-35-3 Usage

General Description

3-ethyl-1,2-dihydroquinoxalin-2-one is a chemical compound with the molecular formula C11H12N2O. It is a quinoxalinone derivative with an ethyl group attached to the nitrogen atom at position 3. 3-ETHYL-1,2-DIHYDROQUINOXALIN-2-ONE has potential pharmaceutical and medicinal applications due to its diverse biological activities. It has been investigated for its antiviral, antifungal, and antibacterial properties, as well as its potential as a therapeutic agent for neurological disorders and cancer. Additionally, 3-ethyl-1,2-dihydroquinoxalin-2-one has been studied for its potential use as an antioxidant and for its ability to inhibit certain enzymes. Further research into the properties and potential uses of this compound may lead to the development of new drugs and therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 13297-35-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,9 and 7 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 13297-35:
(7*1)+(6*3)+(5*2)+(4*9)+(3*7)+(2*3)+(1*5)=103
103 % 10 = 3
So 13297-35-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H10N2O/c1-2-7-10(13)12-9-6-4-3-5-8(9)11-7/h3-6H,2H2,1H3,(H,12,13)

13297-35-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-ethyl-1H-quinoxalin-2-one

1.2 Other means of identification

Product number -
Other names 3-ethyl-1,2-dihydro-2-oxoquinoxaline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13297-35-3 SDS

13297-35-3Relevant articles and documents

Synthesis of 3-alkylquinoxalin-2(1H)-ones via Grignard reaction

Kalinin,Mamedov

, p. 1098 - 1101 (2009)

A two-step procedure has been developed for the synthesis of 3-alkylquinoxalin-2(1H)-ones from o-phenylenediamine and ethyl 2-oxoalkanoates prepared by the Grignard reaction of diethyl oxalate with alkyl bromides. Analogous reaction with α,ω-dibromoalkanes instead of alkyl bromides leads to the formation of 3,3'-(alkane-α,ω-diyl)di[quinoxalin-2(1H) -ones].

Lithiation and Side-Chain Substitution of 3-Alkyl-1H-quinoxalin-2-ones

Smith, Keith,El-Hiti, Gamal A.,Mahgoub, Safaa A.

, p. 2345 - 2348 (2003)

3-Methyl-1H-quinoxalin-2-one has been doubly lithiated with n-butylithium at -78° C in THF. The dilithio reagent thus obtained reacts with various electrophiles (iodomethane, iodoethane, D2O, benzaldehyde, benzophenone, cyclohexanone) to give modified 3-substituted 1H-quinoxalin-2- ones in good yields. In the reaction of the dilithio reagent with phenyl isothiocyanate the product was a tautomer of the simple substitution product. Reaction of the dilithio reagent with iodine gives an oxidatively dimerised product instead of the 3-iodomethyl derivative. Lithiations of 3-ethyl-and 3-propyl-1H-quinoxalin-2-ones, followed by reactions with representative electrophiles (benzaldehyde, benzophenone, cyclohexanone), behaved in a similar manner to give the corresponding modified 3-substituted derivatives in good yields.

Synthesis of potential chemotherapic quinoxalinone derivatives by biocatalysis or microwave-assisted Hinsberg reaction

Gris, Javier,Glisoni, Romina,Fabian, Lucas,Fernández, Beatriz,Moglioni, Albertina G.

, p. 1053 - 1056 (2008)

In recent years, great efforts have been dedicated to the design of compounds acting as selective inhibitors of the HIV-1 reverse transcriptase (RT). Due to the promissory results previously attained with some quinoxaline derivatives, we aimed to improve the specific standard Hinsberg synthetic pathway by means of biocatalysis or microwave (MW) irradiation. Both techniques rendered the products in very good yields. However, employing the microwave-assisted organic synthesis (MAOS), in the absence of solvent, the same reactions may be completed in minutes. Some of these quinoxalinone derivatives exhibited good inhibitor activity against some human tumoral cells and the lymphoma related to HIV-1.

Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress

Loughran, H. Marie,Han, Ziying,Wrobel, Jay E.,Decker, Sarah E.,Ruthel, Gordon,Freedman, Bruce D.,Harty, Ronald N.,Reitz, Allen B.

supporting information, p. 3429 - 3435 (2016/07/21)

We prepared a series of quinoxalin-2-mercapto-acetyl-urea analogs and evaluated them for their ability to inhibit viral egress in our Marburg and Ebola VP40 VLP budding assays in HEK293T cells. We also evaluated selected compounds in our bimolecular complementation assay (BiMC) to detect and visualize a Marburg mVP40–Nedd4 interaction in live mammalian cells. Antiviral activity was assessed for selected compounds using a live recombinant vesicular stomatitis virus (VSV) (M40 virus) that expresses the EBOV VP40 PPxY L-domain. Finally selected compounds were evaluated in several ADME assays to have an early assessment of their drug properties. Our compounds had low nM potency in these assays (e.g., compounds 21, 24, 26, 39), and had good human liver microsome stability, as well as little or no inhibition of P450 3A4.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13297-35-3